NCT07157605 2025-09-05
SPLENDID
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting
Clinical Trials
9 trialsNCT07155629 2025-09-04
LEFT-PANC
Helsinki University Central Hospital
Phase 3 Not yet recruiting
NCT06888674 2025-03-21
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
Zhejiang University
Phase 1/2 Not yet recruiting
NCT06809374 2025-02-05
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
Kochi University
Completed
NCT06722911 2024-12-09
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Zhejiang Provincial People's Hospital
Phase 2 Recruiting
NCT06368063 2024-05-08
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Xi'an Jiaotong University
Phase 4 Recruiting
NCT04224402 2023-02-15
Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.
Sun Yat-sen University
Phase 2 Completed
NCT04736043 2021-02-03
Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid
Samsung Medical Center
Unknown
NCT03344172 2020-05-14
17-134
University of Pittsburgh
Phase 2 Terminated